In keloid fibroblasts (KFs), transforming growth factor (TGF) -β-dependent signalling is closely associated with a variety of keloid pathologic responses such as ECM production and fibroblast overgrowth.
Inhibition of TGF-β signalling would be a potential therapeutic approach to prevent keloid scar formation.